Articles by Chad Landmon - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Chad Landmon

Chad Landmon


Advocating for Biosimilar Approval Standards Under BPCI
September 1, 2011

FDA weighs multiple views regarding the Biologics Price Competition and Innovation Act.

ADVERTISEMENT

ADVERTISEMENT

Click here